Hollencrest Capital Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-500
| Closed | -$7.16K | – | 1173 |
|
|
2024
Q3 | $7.16K | Hold |
500
| – | – | ﹤0.01% | 790 |
|
|
2024
Q2 | $8.1K | Hold |
500
| – | – | ﹤0.01% | 740 |
|
|
2024
Q1 | $50.6K | Hold |
500
| – | – | ﹤0.01% | 487 |
|
|
2023
Q4 | $11.8K | Hold |
500
| – | – | ﹤0.01% | 706 |
|
|
2023
Q3 | $10.1K | Hold |
500
| – | – | ﹤0.01% | 724 |
|
|
2023
Q2 | $13K | Hold |
500
| – | – | ﹤0.01% | 726 |
|
|
2023
Q1 | $10.4K | Hold |
500
| – | – | ﹤0.01% | 738 |
|
|
2022
Q4 | $10.2K | Hold |
500
| – | – | ﹤0.01% | 722 |
|
|
2022
Q3 | $14K | Hold |
500
| – | – | ﹤0.01% | 303 |
|
|
2022
Q2 | $13K | Hold |
500
| – | – | ﹤0.01% | 332 |
|
|
2022
Q1 | $40K | Hold |
500
| – | – | ﹤0.01% | 360 |
|
|
2021
Q4 | $102K | Buy |
+500
| New | +$102K | 0.01% | 355 |
|